Healthequity, Inc.
HQYNasdaqCIK 1428336IndustrialsFiscal year ends Jan 31
Reports and events: 230 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0921:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-26-115084 |
| 2026-09-3013:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure | 0001428336-26-000045 |
| 2026-08-2712:04 ET | 10-Q | Quarterly reportPeriod 2026-07-31 | 0001428336-26-000041 |
| 2026-08-2712:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001428336-26-000040 |
| 2026-06-2620:07 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001428336-26-000034 |
| 2026-05-2820:04 ET | 10-Q | Quarterly reportPeriod 2026-04-30 | 0001428336-26-000028 |
| 2026-05-2820:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001428336-26-000027 |
| 2026-05-1321:25 ET | DEF 14A | Proxy statementPeriod 2026-01-31 | 0001428336-26-000022 |
| 2026-05-0820:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001428336-26-000016 |
| 2026-04-0621:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001428336-26-000014 |
| 2026-03-3021:38 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001428336-26-000012 |
| 2026-03-1720:03 ET | 10-K | Annual reportPeriod 2026-01-31 | 0001428336-26-000010 |
| 2026-03-1720:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001428336-26-000009 |
| 2026-02-1721:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001428336-26-000005 |
| 2026-01-1214:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001428336-26-000003 |
| 2025-12-0321:04 ET | 10-Q | Quarterly reportPeriod 2025-10-31 | 0001428336-25-000036 |
| 2025-12-0321:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001428336-25-000035 |
| 2025-09-0220:03 ET | 10-Q | Quarterly reportPeriod 2025-07-31 | 0001428336-25-000029 |
| 2025-09-0220:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001428336-25-000028 |
| 2025-06-2720:02 ET | 8-K | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001428336-25-000024 |
| 2025-06-0320:05 ET | 10-Q | Quarterly reportPeriod 2025-04-30 | 0001428336-25-000022 |
| 2025-06-0320:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001428336-25-000021 |
| 2025-05-1320:01 ET | DEF 14A | Proxy statementPeriod 2025-01-31 | 0001428336-25-000016 |
| 2025-04-2820:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001428336-25-000011 |
| 2025-03-1820:22 ET | 10-K | Annual reportPeriod 2025-01-31 | 0001428336-25-000009 |
| 2025-03-1820:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001428336-25-000008 |
| 2025-02-1821:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001428336-25-000004 |
| 2025-01-1314:12 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001428336-25-000002 |
| 2024-12-0921:03 ET | 10-Q | Quarterly reportPeriod 2024-10-31 | 0001428336-24-000110 |
| 2024-12-0921:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001428336-24-000109 |
| 2024-11-2918:02 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001428336-24-000106 |
| 2024-11-1221:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001428336-24-000104 |
| 2024-09-0320:04 ET | 10-Q | Quarterly reportPeriod 2024-07-31 | 0001428336-24-000102 |
| 2024-09-0320:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001428336-24-000101 |
| 2024-08-2720:01 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001428336-24-000098 |
| 2024-07-0220:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001428336-24-000055 |
| 2024-06-2720:03 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001428336-24-000048 |
| 2024-06-0320:05 ET | 10-Q | Quarterly reportPeriod 2024-04-30 | 0001428336-24-000036 |
| 2024-06-0320:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001428336-24-000035 |
| 2024-05-2820:31 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001428336-24-000032 |
| 2024-05-1712:02 ET | DEF 14A | Proxy statementPeriod 2024-01-31 | 0001428336-24-000027 |
| 2024-05-1411:32 ET | 8-K | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001428336-24-000022 |
| 2024-04-2520:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001428336-24-000020 |
| 2024-04-1520:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001428336-24-000018 |
| 2024-03-2220:01 ET | 10-K | Annual reportPeriod 2024-01-31 | 0001428336-24-000016 |
| 2024-03-1920:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001428336-24-000009 |
| 2024-03-1320:08 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001428336-24-000007 |
| 2024-02-2121:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001428336-24-000005 |
| 2024-01-0814:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001428336-24-000002 |
| 2023-12-0521:07 ET | 10-Q | Quarterly reportPeriod 2023-10-31 | 0001428336-23-000037 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:09 ET. Listed shows no prices and gives no investment advice.